Change - Announcement of Cessation::Change - Announcement of Cessation

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Securities
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
15-May-2015 19:41:36
Status
New
Announcement Sub Title
Change - Announcement of Cessation
Announcement Reference
SG150515OTHR9RQB
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Independent Director

Additional Details

Name Of Person
Mr Gao Xue Min
Age
77
Is effective date of cessation known?
Yes
If yes, please provide the date
15/05/2015
Detailed Reason (s) for cessation
Mr Gao Xue Min had ceased to be an independent director of the Company as of 15 May 2015, as he did not stand for re-election as a director at the Company s annual general meeting held on 15 May 2015.

Mr Gao Xue Min s cessation as an independent director is in compliance with Article 14 under the Guidelines of Filing and Training for Independent Director in the Listed Companies promulgated by the Shanghai Stock Exchange in 2010, where it is stated that an independent director cannot serve on the board of a listed company for more than six years.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
15/05/2015
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, a member of the Audit Committee and the Strategy Committee, Chairman of the Nomination Committee.
Role and responsibilities
Duties as an Independent Director, a member of the Audit Committee and the Strategy Committee, Chairman of the Nomination Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
NIL
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Beijing Tongrentang Co., Ltd.
Present
(a) Heilongjiang Kuihua Pharmaceutical Co., Ltd.
(b) Tianjin Zhongxin Pharmaceutical Group Co., Ltd
(c) Shanxi Panlong Pharmaceutical Group Co., Ltd.